A Houston Methodist research team received a nearly $4 million grant to test a transcutaneously refillable implant that administers pre-exposure prophylaxis drugs to subjects at risk of HIV-exposure.

Read More:
Researchers receive grant to test transcutaneously refillable implant that delivers HIV-prevention drugs